Clearance of microparticulate fibrin by the reticuloendothelial system has been long recognized as a defense mechanism against intravascular fibrin deposition (1, 2). In general this has been assumed to be part of the relatively nonspecific phagocytic process whereby the reticuloendothelial system removes other microparticulate material such as bacteria, from the circulation. Numerous in vitro studies (3-7) have documented the fact that before formation of particulate fibrin, fibrin may exist in a soluble form, generally when in a soluble complex with fibrinogen, and/or fibrin degradation products (5-7). Recently we have demonstrated that soluble macromolecular complexes consisting of known ratios of fibrinogen and fibrin which were formed in vitro, remain soluble when injected into rabbits (7). These complexes also had impaired clearance from blood during reticuloendothelial system blockade with Thorotrast. In nonblockaded animals, the blood tl/2 of the fibrinogen/fibrin complex was less than 1 h. The results indicated that in part reticuloendothelial system uptake of fibrin depended on specific binding of soluble fibrin, before microparticle formation and phagocytosis. Specificity for fibrin was suggested, because in the same Thorotrast model we were unable to demonstrate impaired clearance of fibrinogen degradation product D (8), and intact fibrinogen had a normal blood tV2. Removal of soluble fibrinogen/fibrin complexes is of pathophysiological significance because of the clear, frequent clinical association of these complexes with intravascular coagulation (9-12), in contrast to the very rare demonstration of circulating microparticulate fibrin.
was redissolved in 0.27 M Tris HC1, 0.03 M Tris-acetate buffer, pH 5.3, as previously described (7) . In some instances, the soluble fibrin was added to fibrinogen to form fibrin/fibrinogen complexes (f/F). These complexes are large polymers which emerge at the void volume on Sepharose 4B and have a Ve/Vo of 1.17 on Sepharose 2B. A double labeled ~25I-f/13'I-F preparation illustrates that both F and f are present in the void volume complex (Fig. 1) . A second peak contains some noncomplexed F and a small variable amount of f. The second peak corresponds to the Ve of F alone. '25I-f alone emerges at the void volume with a small amount in the F position (7) . Thrombin neutralization was accomplished with 10 -2 M diisopropylfluorophosphate. In some instances f was formed in the presence of Ca ++ so as to obtain cross-linked f. "Late" crude plasmin digests of F (F degradation products) were prepared by addition of 30 U streptokinase to 24 mg F in 0.1 M Tris-C1 buffer, pH 8.4 , and incubation at 37°C for 18 h. Late fibrin degradation products were similarly prepared except that thrombin was added just before the streptekinase. For "early" fibrin degradation products, soy bean trypsin inhibitor (SBTI) was added at the time of clot dissolution.
Macrophages. Guinea pig peritoneal macrophages were harvested 3 days after intraperitoneal injection of 20 ml Marcol 52 (Humble Oil & Refining Co., Houston, Texas) (15) . The cell suspension was washed and resuspended in RPMI 1640, with 10% fetal calf serum. The cells were incubated in glass Petri dishes for 18 h at 37°C in 5% CO2. The contaminating lymphocytes were poured off, and the adherent macrophages washed with Hanks' balanced salt solution (HBSS). The macrophages were harvested with a rubber policeman, washed, and resuspended in HBSS. Resuspended macrophages were ->90% viable by trypan blue exclusion and ->90% of the cells phagocytized yeast particles.
Other Cell Types. Washed guinea pig lymphocyte suspensions were prepared from the nonadherent cells after overnight culture of the Marcol-induced peritoneal exudates. Cultures of human skin fibroblasts were kindly supplied by Dr. Nancy Baenziger. Guinea pig peritoneal polymorphonuclear leukocytes (PMNs) were harvested 18 h after injection of 20 ml of 6% caseinate (15) . The exudates contained ->96% PMNs.
Experimental. For most experiments 1.5 x 106 cells were suspended in HBSS or 0.007 M NaH2PO4, 0.15 M NaC1, pH 7.4 buffer, in Falcon 12 × 75 mm tubes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) Cellular metabolism was inhibited with either 1 x 10 2 M NaF and 2 × 10 -2 M KCN or 20 mM 2-deoxyglucose and 1 mg/ml sodium azide. Varying amounts of '25I-for ~25I-f/ F were then added and the total radioactivity measured. Unless so indicated, incubations were for 45 min. 22°C was usually employed because it was desirable to avoid enhanced metabolic activity at 37°C, yet f is poorly soluble at 4°C. The experiments comparing maerophages, lymphecytes, fibroblasts, and erythrocytes were at 37°C because it is known that f/F will bind soluble fibroblast surface antigen, or cold-insoluble globulin (CIG), at low temperatures, but not at 37°C. After incubation, the ceils were centrifuged for 5 min at 2,500 g and 22°C, and the supernate removed. Two washes of the cells with HBSS were performed. Preliminary studies demonstrated that no additional radioactivity was removed by added washes. The cell-bound radioactivity was determined in a Packard dual channel gamma counter (Packard Instrument Co., Inc., Downers Grove, Ill.). In instances when both ~zq and '25I were used, the 'z~I counts were corrected for the scatter of ~a~I counts into the '~I channel. Blank controls with ~I-f or '25I-f/F but without cells were also run.
Centrifugation of-<20 ttg '25I-f or -<500 /zg ~2~I-f/F in HBSS at 7-10,000 g for 20 min without cells, showed neither a precipitate nor significant change in the specific activity of the solution. This is in keeping with previous data (7) that the f/F complex remains both soluble, and as a complex, in the blood of animals after injection of f/F. All tests were run in duplicate or triplicate. The amount bound was usually expressed as micrograms per l0 s cells, and was corrected for the blank controls, which did not exceed 5% of the cell-bound values.
Specificity. The specificity of binding was assessed first by the effect of prior incubation of the cells with nonradioactive f and F. Secondly the interaction with the IgG receptor was assessed for both IgG and immune complexes. For immune complexes, rat IgE and goat anti-IgE were kindly supplied by Dr. A. Kulczycki (16) . A 25-fold range of IgE was used so as to span the previously determined range of equivalence. The antisera concentration was 0.15 ml in 0.5 ml final test vol. The same amount of human IgG was used for IgG alone. Human IgG was prepared by ion exchange chromatography and was immunoelectrophoretically homogeneous using anti-human IgG and anti-whole human sera (Behring Diagnostics, American Hoechst Corp., Somerville, N. J.). Because of the high protein concentration, a control with a similar amount of human serum albumin (Hyland Laboratories, Los Angeles, Calif.) was run.
Effects of Trypsin and Plasmin
PRETREATMENT. Cells were preincubated with either 0.25 mg/ml trypsin (Sigma Chemical Co., St. Louis, Mo.) and 0.4 mg/ml ribonuclease (Worthington Biochemical Corp., Freehold, N. J.), or 3 Committee on Thrombolytic Agents (CTA) U plasmin (17) for 30 min at 37°C. 0.5 mg/ml SBTI was added, the supernate removed, and the cells washed twice and resuspended for addition of labeled f or f/F. POSTFIBRIN EXPOSURE. In other experiments, after incubation with radiolabeled f or f/F, the ceils were centrifuged, washed, and the bound radioactivity counted. HBSS was readded with 1 mg/ml of trypsin or 3 CTA ~ U plasmin for 20 min at 37°C. The cells were recentrifuged, washed, and radioactivity recounted.
Effect of Divalent Cations. The macrophages were suspended in HBSS solution with metabolic inhibitors, without Ca ++ or Mg ++, and 125I-f added. Other tubes had 0.9 mM CaC12 or 0.5 mM MgC1, and 0.4 mM MgSO4 added before addition of the ~25I-f. The entire experiment was run with both cross-linked and noncross-linked l~sI-f. Experiments with noncross-linked f and Ca ++ utilized 10 -3 M iodacetamide to inhibit any trace F XIII activity. (Table I ). In the standard incubations both fand f/F complexes were bound to the macrophages. Intact F, late F degradation products, and late f degradation products were bound in much smaller amounts. When early 125I-f degradation products were mixed with F before addition to the tubes, 1.5 /zg early 12~I-f degradation products was bound per l0 s cells. No such enhanced binding was observed when F and early F degradation products were mixed together before addition to the cells. Binding was progressive until 30 rain and remained essentially constant thereafter (Table II) .
Results

Binding of Derivatives
Localization of 125I-f.
To differentiate between membrane-bound and intracellular 125I-f, after incubation with ~25I-f, cells were washed, counted, and reincubated with plasmin or trypsin (Table III a) . Essentially, all the cell-bound radioactivity was removed, by either enzyme. (Table  III b Fig. 2) . Scat- 
Binding Sensitivity to Pretreatment with Plasmin and Trypsin
Reversibility and Displacement.
With an incubation of 1 tzg f with 1.5 × 10 s cells for 45 min, 14% (0.14 tzg) was bound. Subsequent dilution to 10 ml with addition of 50 tLg nonradiolabeled f and reincubation for 45 min failed to displace any 12sI-f. Similar experiments with ratios of 10-800:1 of "cold": 125I-f and incubation for up to 180 min, all failed to demonstrate significant displacement. Prolonged incubation of cells with ~25I-f alone did not show either significant further uptake after 45 min, or release of radioactivity. Displacement only occurred in three experiments with cold f: ~2~I-f ratios of 500:1 and a 20 h incubation period. 31 _+ 10% of the cell-bound radioactivity was released. In contrast cells incubated without metabolic inhibitors showed sustained increases in radioactivity (Fig. 4) . After overnight incubation without inhibitors, Incubation mixture included 1.5 × 10 e cells and 10 ~g l~sI-f. Tubes 3-6 had 0.15 ml of undiluted goat antisera added per tube. The amount bound with 12sI-fand cells alone was considered 100%. The results are the average of three experiments with albumin and two experiments with the others.
11% of the unbound 125I was TCA soluble, indicating cellular proteolysis of 125I-f with release of free 12sI.
Specificity. Prior incubation of cells with 100 P4g nonradioactive f/F reduced uptake of 10 ~g 125I-fby 71 _+ 4% in three experiments. Preincubation with a 10-fold excess of F failed to inhibit uptake of ~25I-f. Immune complexes and IgG alone inhibited uptake by 14-24% (Table IV) . A similar decrease was seen with albumin. The modest nature of the decreased uptake in light of the 200-and 3,000-fold molar excesses of IgG and albumin suggests the effect was nonspecific. The f uptake with albumin (1.48 p~g/106 cells) may represent a physiological state, more comparable to in vivo conditions, than with HBSS alone.
Effect of Divalent Cations (Table V). When the 125I-f uptake was tested in
Hanks' solution without Ca ++ or Mg +÷, negligible uptake occurred. Addition of Ca ÷+ alone restored f binding, whereas Mg ÷+ alone had no effect. The effect of Ca +÷ was present with both cross-linked fibrin and noncross-linked f.
Other Cell Types. A limited number of studies were performed with PMNs.
The same enhanced binding of f vs. F was found as with the macrophages. Substantially greater amounts of f were bound to PMNs as compared with macrophages. In the presence of 10 ~g f and NaF and KCN, 4.9 _+ 0.4 ~g 125I-f bound/106 cells in five experiments. Lymphocytes, fibroblasts, and erythrocytes bound relatively little ~25I-ffF, as compared with macrophages and PMNs. The lymphocytes and fibroblasts bound approximately as much F as f (Table VI) . Discussion The cellular uptake of soluble f and f/F complexes described above would appear to be the result of cell surface binding. Intracellular ingestion was prevented by use of metabolic inhibitors. Subsequent removal of the cell-bound f by trypsin and plasmin was added evidence that the f was on the outside of the cells. A major concern was the possibility that the f and f/F were artifactually precipitated or polymerized with the cells. The low binding in the blank controls and other cell types except PMNs (Table VI) , and the unchanged specific radioactivity of 12~I-f and l~I-f/F in HBSS after centrifugation, are evidence against precipitation. Additionally, saturation of uptake above 300 ~g (Fig. 2) and the blocking of uptake by cold f/F makes precipitation unlikely. If precipitation, or further polymerization were occurring, increasing amounts of cell radioactivity would result from increasing the f/F concentration. In fact an increasing percentage of cell-bound f would be expected, and the opposite occurred.
The high uptake of 125I-f by PMNs is not clearly explicable. Cellular metabolism may have been incompletely inhibited, however, as with the macrophages, virtually all the cell-bound 125I-f could be removed by subsequent plasmin or trypsin treatment. PMNs have been previously shown to have a great capacity to phagocytize and lyse particulate f. Lewis et al. (18) demonstrated 200-320 × l0 s cells could lyse 6 mg particulate f in 3 h. This area requires further investigation.
The nature of the binding site on the macrophage is unknown. The possibilities existed of previously absorbed or synthesized F, f, or CIG binding the ~2sI-f and ~25I-f/F. CIG is a recently described plasma protein (19) which can be crosslinked to f (20) and is thought to be identical to fibroblast surface antigen (21) .
The likelihood of cellular F or f binding the 125I-f was essentially eliminated by continued binding after pretreatment with trypsin or plasmin. CIG is also susceptible to trypsin and plasmin (M. W. Mosesson, personal communication). Additionally, in the experiment comparing macrophages, lymphocytes, and fibroblasts (Table VI) , the macrophages bound fat 37°C. CIG has been reported not to bind f at 37°C (21) . Although not excluded, it is unlikely that other adherent proteins, or residual F or CIG fragments, might bind f, but rather some type of membrane receptor is involved. The rapid uptake of f and f/F is similar to that noted for IgG and complement. The quantitative relation between number of f molecules bound and the number of binding sites per cell is uncertain because the protein is not monomeric. In the conditions employed, both f and f/F exist as macromolecular complexes, of an unknown mean number of molecules. Therefore the number of binding sites per cell is less than 6.92 × 106, as each site binds a polymer containing several f molecules. The number of molecules bound is comparable to the results reported for IgG-binding sites of 0.4-2.5 × 106 per cell (22) (23) (24) (25) .
Relatively little F, late F degradation products, and late f degradation products were bound as compared to f, implying a specificity of uptake that is unique to relatively intact f. The observed uptake of ~alI-F in f/F complexes was expected based on our previous data (7) indicating the complex is stable in a soluble state. Early f degradation products have also been noted to form large complexes (6). Colvin and Dvorak (26) described macrophage uptake of homologous F using immunofluorescence to detect the protein. It was also surmised that some of the material was f because of a net-like pattern which was absent in warfarintreated animals. Direct evidence for f binding was not obtained. As in the present results, Ca ++ was necessary for binding. Our results suggest that f binding may be by a different mechanism than F in that preincubation with F did not block 12~I-f uptake, whereas preincubation with f did. The binding of F in the study of Colvin and Dvorak and in the present results may be secondary to several phenomena. It is very difficult to avoid slight denaturation of F during purification and radiolabeling (27) . This denatured fraction is rapidly cleared from the blood after injection (28) , presumably in the liver and spleen. Part of the small amount of F bound could represent denatured material. Conversely Colvin and Dvorak's positive results with direct staining of cells without prior incubation in plasma would suggest that nonartifactual binding does occur, at least in part. They have hypothesized that F is important in macrophage adherence. The quantitatively greater amounts of f binding found here and the evidence for ingestion noted here (Fig. 4) , and by Chang and Boxer (29) , indicate a different role for f binding.
Soluble f binding would appear to be the initial step in blood f clearance before ingestion and intracellular catabolism. The very limited reversibility of f binding would be in keeping with this function. It would appear that via this mechanism, the reticuloendothelial system is capable of preventing thrombus formation before formation of microparticulate f. The quantitative differences in binding of F, f, F degradation products, and f degradation products, suggest a fine biochemical discrimination on the cell surface, in keeping with such a homeostatic role.
Summary
Guinea pig peritoneal macrophages were demonstrated to bind selectively soluble 125I-fibrin and fibrin/fibrinogen complexes as compared with fibrinogen, fibrinogen degradation products, and fibrin degradation products. Cellular uptake was considered to be surface receptor binding on the basis of removal of bound 125I-fibrin by trypsin and because uptake occurred in the presence of metabolic inhibitors. 125I-fibrin uptake could be blocked by nonradioactive fibrin but not by IgG or immune complexes. Binding was uneffected by prior treatment with plasmin or trypsin but was calcium dependent. Only limited reversibility of binding could be demonstrated after prolonged incubation. Scatchard plots permitted an estimate of the number of bound molecules. At saturation 6.92 × 106 125I-fibrin molecules were bound per cell. Similar binding of fibrin was noted in polymorphonuclear leukocytes, but not lymphocytes or fibroblasts. Soluble fibrin binding may be a host defense mechanism whereby the reticuloendothelial system can remove fibrin from the blood before the development of microthrombi.
